Furthermore, the HCC exosomes-increased lactate uptake in macrophages could be obviously attenuated by treatment with SLC16A1 knockdown or specific inhibitor of SLC16A1 (AZD3965) (Fig. 4B, C). The gene discussed is SLC16A1; the disease is hepatocellular carcinoma.